<DOC>
	<DOCNO>NCT00998608</DOCNO>
	<brief_summary>The purpose study compare efficacy safety risperidone risperidone plus low dose haloperidol acutely schizophrenic patient .</brief_summary>
	<brief_title>Comparison Efficacy Safety Risperidone Versus Risperidone Plus Low Dose Haloperidol Treatment Schizophrenia</brief_title>
	<detailed_description>Antipsychotic monotherapy recognize treatment choice patient schizophrenia . Surveys show antipsychotic drug combination frequently prescribe , yet clinical study examine practice . Risperidone , atypical antipsychotic , low incidence extrapyramidal symptom ( EPS ) high cost compare haloperidol . It report relatively low daily dose haloperidol individual patient develop slightly increase EPS neurocognitive benefit risperidone . The objective study compare efficacy safety fixed-dosed risperidone risperidone combine haloperidol treatment acute psychotic exacerbation schizophrenia.In 6-week , double-blind , fixed-dose study , patient schizophrenic disorder ( DSM-IV diagnosis ) randomly assign risperidone ( 4 mg/d ) risperidone ( 2 mg/d ) plus haloperidol ( 2 mg/d ) . The hypothesis two treatment group similar efficacy safety , different cost . The primary efficacy measure change baseline Positive Negative Syndrome Scale ( PANSS ) total score ; secondary outcome include Clinical Global Impression-Change ( CGI-C ) , Calgary Depression Scale Schizophrenics ( CDSS ) , subject-reported outcome via Short Form-36 ( SF-36 ) , auditory evoke potential ( AEPs ) , cognitive social functioning . Safety assessment include change baseline Simpson-Angus Rating Scale ( SAS ) , Abnormal Involuntary Movement Scale ( AIMS ) , Barnes Akathisia Scale ( BAS ) , UKU Side-effects Rating Scale ( UKU ) , change baseline prolactin level , body weight , AC glucose level , lipid panel ( cholesterol , high density lipid protein [ HDL ] , low density lipid protein [ LDL ] , triglyceride [ TG ] )</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis schizophrenia Clinical Global Impression large 3 Written inform consent Comorbid substance abuse/dependence Present history tardive dyskinesis neuroleptic malignant syndrome Severe physical problem pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>